loading
Schlusskurs vom Vortag:
$0.204
Offen:
$0.2015
24-Stunden-Volumen:
73,839
Relative Volume:
0.26
Marktkapitalisierung:
$7.91M
Einnahmen:
$20.27M
Nettoeinkommen (Verlust:
$-63.80M
KGV:
-0.1359
EPS:
-1.52
Netto-Cashflow:
$-68.35M
1W Leistung:
-2.97%
1M Leistung:
-37.70%
6M Leistung:
-79.64%
1J Leistung:
-87.69%
1-Tages-Spanne:
Value
$0.1937
$0.2073
1-Wochen-Bereich:
Value
$0.1937
$0.2296
52-Wochen-Spanne:
Value
$0.1601
$1.90

Carisma Therapeutics Inc Stock (CARM) Company Profile

Name
Firmenname
Carisma Therapeutics Inc
Name
Telefon
(267) 491-6422
Name
Adresse
3675 MARKET STREET, PHILADELPHIA
Name
Mitarbeiter
46
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
CARM's Discussions on Twitter

Vergleichen Sie CARM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CARM
Carisma Therapeutics Inc
0.2039 7.91M 20.27M -63.80M -68.35M -1.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
505.25 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
565.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
629.99 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
258.61 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.45 24.70B 3.81B -644.79M -669.77M -6.24

Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-12 Herabstufung Robert W. Baird Outperform → Neutral
2024-12-10 Herabstufung BTIG Research Buy → Neutral
2024-04-11 Eingeleitet BTIG Research Buy
2023-10-03 Eingeleitet CapitalOne Overweight
2023-07-06 Eingeleitet Evercore ISI Outperform
2023-05-31 Hochstufung Jefferies Hold → Buy
2023-05-24 Eingeleitet H.C. Wainwright Buy
2023-04-14 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Carisma Therapeutics Inc Aktie (CARM) Neueste Nachrichten

pulisher
Apr 28, 2025

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

Apr 28, 2025
pulisher
Apr 23, 2025

Carisma Therapeutics to Present at Upcoming Conferences - Seeking Alpha

Apr 23, 2025
pulisher
Apr 16, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Given Average Rating of “Hold” by Analysts - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Sagimet Biosciences (NASDAQ:SGMT) and Carisma Therapeutics (NASDAQ:CARM) Head-To-Head Review - Defense World

Apr 15, 2025
pulisher
Apr 08, 2025

Philly weekly roundup: Carisma Therapeutics layoffs; PPA's AI ticketing; HiveBio's first cohort - Technical.ly

Apr 08, 2025
pulisher
Apr 07, 2025

Carisma Therapeutics Inc’s Market Journey: Closing Weak at 0.19, Down -0.26 - DWinneX

Apr 07, 2025
pulisher
Apr 06, 2025

CARISMA THERAPEUTICS Earnings Preview: Recent $CARM Insider Trading, Hedge Fund Activity, and More - Nasdaq

Apr 06, 2025
pulisher
Apr 03, 2025

Carisma Therapeutics Focuses on Strategic Alternatives Amid Revised Operating Plan - MSN

Apr 03, 2025
pulisher
Apr 02, 2025

Philly’s Carisma Therapeutics slashed its workforce to 6 from 46 for sale or wind down - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

Carisma Therapeutics (NASDAQ:CARM) Price Target Lowered to $1.00 at D. Boral Capital - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Carisma Therapeutics to Present at AASLD 2024 on Liver Fibrosis Treatment - MSN

Apr 01, 2025
pulisher
Apr 01, 2025

Carisma winds down operations, lays off 95% of remaining staff - Fierce Biotech

Apr 01, 2025
pulisher
Mar 31, 2025

Penn spinout Carisma Therapeutics lays off 84% of its staff, explores possible sale - The Business Journals

Mar 31, 2025
pulisher
Mar 31, 2025

Carisma Therapeutics Provides Corporate Updates - Citizen Tribune

Mar 31, 2025
pulisher
Mar 31, 2025

Carisma Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Carisma Therapeutics Board Approves Revised Operating Plan; Reduces Workforce - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

Carisma Therapeutics Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 28, 2025

Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Business And Shares Still Trailing The Industry - simplywall.st

Mar 28, 2025
pulisher
Mar 28, 2025

Carisma Therapeutics (CARM) to Release Earnings on Monday - Defense World

Mar 28, 2025
pulisher
Mar 22, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives Consensus Rating of “Hold” from Analysts - Defense World

Mar 22, 2025
pulisher
Mar 19, 2025

Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 19, 2025
pulisher
Mar 13, 2025

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annua - GuruFocus.com

Mar 13, 2025
pulisher
Feb 25, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

Feb 25, 2025
pulisher
Feb 22, 2025

Michael Klichinsky to Speak at H.C. Wainwright Cell Therapy Virtual Conference - MSN

Feb 22, 2025
pulisher
Feb 19, 2025

Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024 - Quantisnow

Feb 19, 2025
pulisher
Feb 19, 2025

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - Quantisnow

Feb 19, 2025
pulisher
Feb 11, 2025

Carisma Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Conference - MSN

Feb 11, 2025
pulisher
Feb 05, 2025

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - Quantisnow

Feb 05, 2025
pulisher
Feb 04, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Short Interest Update - Defense World

Feb 04, 2025
pulisher
Jan 31, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 30, 2025
pulisher
Jan 29, 2025

Biliary Tract Cancer Market Poised for Significant Growth from - openPR.com

Jan 29, 2025
pulisher
Jan 22, 2025

BTIG Downgrades Carisma Therapeutics (CARM) - MSN

Jan 22, 2025
pulisher
Jan 18, 2025

Evercore ISI Group Downgrades Carisma Therapeutics (CARM) - MSN

Jan 18, 2025
pulisher
Jan 18, 2025

Barclays PLC Has $539,000 Holdings in Carisma Therapeutics, Inc. (NASDAQ:CARM) - Defense World

Jan 18, 2025

Finanzdaten der Carisma Therapeutics Inc-Aktie (CARM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):